INVALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Patients who meet 1987 ACR criteria for SLE with   │ Patients who meet 1987 ACR criteria for SLE with   │     100 │
│ 1996 modifications                                 │ 1996 modifications                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Positive ANA OR anti-dsDNA within one year of      │ Positive ANA OR anti-dsDNA within one year of      │     100 │
│ screening                                          │ screening                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ In the opinion of the investigator there is intent │ In the opinion of the investigator there is intent │     100 │
│ to treat with a biologic (e.g. patient failed      │ to treat with a biologic (e.g. patient failed      │         │
│ standard of care treatment) however there is no    │ standard of care treatment) however there is no    │         │
│ organ threatening disease                          │ organ threatening disease                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ SLEDAI \>/= 6 at screening visit                   │ SLEDAI >/= 6 at screening visit                    │      98 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Lymphocyte count less than 0.4                     │ Positive ANA OR anti-dsDNA within one year of      │      28 │
│                                                    │ screening                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ AST/ALT greater than 2.5 times ULN                 │ SLEDAI >/= 6 at screening visit                    │      31 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Hg less than 8.0 or hemolytic anemia               │ Patients who meet 1987 ACR criteria for SLE with   │      33 │
│                                                    │ 1996 modifications                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Inability or unwillingness to follow the protocol  │ Patients who meet 1987 ACR criteria for SLE with   │      33 │
│                                                    │ 1996 modifications                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 16 Years                  │ Positive ANA OR anti-dsDNA within one year of      │      34 │
│                                                    │ screening                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 70 Years                  │ Positive ANA OR anti-dsDNA within one year of      │      34 │
│                                                    │ screening                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Cancer within 5 years (except for completely       │ In the opinion of the investigator there is intent │      39 │
│ excised cervical carcinoma in situ or excised non- │ to treat with a biologic (e.g. patient failed      │         │
│ melanoma skin cancer)                              │ standard of care treatment) however there is no    │         │
│                                                    │ organ threatening disease                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ -                                                  │ Positive ANA OR anti-dsDNA within one year of      │       4 │
│                                                    │ screening                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Active chronic infections (such as tuberculosis)   │ In the opinion of the investigator there is intent │      41 │
│ which have not been treated or tb exposure in a    │ to treat with a biologic (e.g. patient failed      │         │
│ person under 40 who has not received suppressive   │ standard of care treatment) however there is no    │         │
│ therapy for at least 3 months. Herpes zoster       │ organ threatening disease                          │         │
│ outbreak within three months of dosing.            │                                                    │         │
│ (Suppressive therapy for herpes simplex is not an  │                                                    │         │
│ exclusion criterion)                               │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Infection requiring IV antibiotics within a month  │ In the opinion of the investigator there is intent │      42 │
│ of screening or oral antibiotics within two weeks  │ to treat with a biologic (e.g. patient failed      │         │
│ of first dose                                      │ standard of care treatment) however there is no    │         │
│                                                    │ organ threatening disease                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ If WOCBP, inability or unwillingness to practice   │ In the opinion of the investigator there is intent │      44 │
│ an acceptable method of contraception (including   │ to treat with a biologic (e.g. patient failed      │         │
│ abstinence, barrier method with spermicide, or     │ standard of care treatment) however there is no    │         │
│ hormonal treatment                                 │ organ threatening disease                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Inability or unwillingness to withdraw from        │ In the opinion of the investigator there is intent │      45 │
│ hydroxychloroquine and/or any immune suppressive   │ to treat with a biologic (e.g. patient failed      │         │
│ therapy being taken despite option for immediate   │ standard of care treatment) however there is no    │         │
│ steroid treatment and later treatment rescues as   │ organ threatening disease                          │         │
│ needed                                             │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any illness or condition that, in the opinion of   │ In the opinion of the investigator there is intent │      45 │
│ the investigator, would cause undue hardship or    │ to treat with a biologic (e.g. patient failed      │         │
│ risk to the subject by participating in the        │ standard of care treatment) however there is no    │         │
│ protocol                                           │ organ threatening disease                          │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒═══════════════════════════════════════════════╤═════════════════╤═════════╕
│ Personal Criteria                             │ CHIA Criteria   │   Score │
╞═══════════════════════════════════════════════╪═════════════════╪═════════╡
│ Positive ANA OR anti-dsDNA within one year of │ NA              │       7 │
│ screening                                     │                 │         │
╘═══════════════════════════════════════════════╧═════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 34
Average Levenshtein Ratio of individual lines: 47.666666666666664
OverAll Ratio: 40.83333333333333
